Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months

AbstractBackground.Cerebral glutamate and gamma-aminobutyric acid (GABA) levels might predict clinical outcome in individuals at ultrahigh risk (UHR) for psychosis but have previously primarily been investigated in smaller cohorts. We aimed to study whether baseline levels of glutamate and GABA in a...

Full description

Bibliographic Details
Main Authors: C. Wenneberg, B. Y. Glenthøj, L. B. Glenthøj, B. Fagerlund, K. Krakauer, T. D. Kristensen, C. Hjorthøj, R. A. E. Edden, B. V. Broberg, K. B. Bojesen, E. Rostrup, M. Nordentoft
Format: Article
Language:English
Published: Cambridge University Press 2020-01-01
Series:European Psychiatry
Subjects:
1H-MRS
GABA
glutamate
outcome
prodromal
UHR
Online Access:https://www.cambridge.org/core/product/identifier/S0924933820000772/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S0924933820000772/type/journal_article

Similar Items